These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 2563844)

  • 1. Secondary prevention of coronary disease with lipid-lowering drugs.
    Lancet; 1989 Mar; 1(8636):473-4. PubMed ID: 2563844
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary prevention of ischaemic heart disease with lipid-lowering drugs.
    Lancet; 1988 Feb; 1(8581):333-4. PubMed ID: 2893141
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid lowering in post-MI patients with normal cholesterol.
    Lawless C; Force R
    J Fam Pract; 1997 Jan; 44(1):30. PubMed ID: 9010366
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta receptor blocking agents in the secondary prevention of coronary heart disease.
    Vedin JA; Wilhelmsson CE
    Annu Rev Pharmacol Toxicol; 1983; 23():29-44. PubMed ID: 6135389
    [No Abstract]   [Full Text] [Related]  

  • 5. Commentary on the published results of the Lipid Research Clinics Coronary Primary Prevention Trial.
    Kronmal RA
    JAMA; 1985 Apr; 253(14):2091-3. PubMed ID: 3883022
    [No Abstract]   [Full Text] [Related]  

  • 6. Niacin as a component of combination therapy for dyslipidemia.
    Miller M
    Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary prevention study yields proof of cholesterol link.
    Schrott HG
    Iowa Med; 1984 Apr; 74(4):143-6. PubMed ID: 6376416
    [No Abstract]   [Full Text] [Related]  

  • 8. The Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
    Rifkind BM
    Monogr Atheroscler; 1985; 13():74-84. PubMed ID: 3911061
    [No Abstract]   [Full Text] [Related]  

  • 9. Niacin: a powerful adjunct to other lipid-lowering drugs in reducing plaque progression and acute coronary events.
    Davidson MH
    Curr Atheroscler Rep; 2003 Sep; 5(5):418-22. PubMed ID: 12911853
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucose.
    Sazonov V; Maccubbin D; Sisk CM; Canner PL
    Int J Clin Pract; 2013 Apr; 67(4):297-302. PubMed ID: 23521322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Royal College of Physicians of Edinburgh Consensus Conference on lipid lowering to prevent vascular events 17 & 18 March 1999.
    Scott Med J; 1999 Jun; 44(3):73-4. PubMed ID: 10461692
    [No Abstract]   [Full Text] [Related]  

  • 12. Niacin: its value in raising HDL cholesterol is being questioned.
    Heart Advis; 2011 Oct; 14(10):7. PubMed ID: 23019714
    [No Abstract]   [Full Text] [Related]  

  • 13. [Niacin--an additive therapeutic approach for optimizing lipid profile].
    Wieneke H; Schmermund A; Erbel R
    Med Klin (Munich); 2005 Apr; 100(4):186-92. PubMed ID: 15834527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [China coronary secondary prevention study (CCSPS)].
    Lu ZL;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):109-15. PubMed ID: 15924803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lovastatin to prevent acute coronary events with average cholesterol levels.
    MacFarlane LL; Carek PJ
    J Fam Pract; 1998 Aug; 47(2):91-2. PubMed ID: 9722787
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid lowering drugs and coronary heart disease.
    Scott PJ
    Drugs; 1975; 10(3):218-25. PubMed ID: 1104340
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiographic trials of lipid-lowering therapy: end of an era?
    Thompson GR
    Br Heart J; 1995 Oct; 74(4):343-7. PubMed ID: 7488443
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipid lowering therapy for primary prevention of coronary heart disease--contra lipid lowering therapy].
    Berger M
    Z Kardiol; 1998; 87 Suppl 2():210-3. PubMed ID: 9827485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yanagi K; Yamashita S; Takemura K; Matsuzawa Y
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):1088-94. PubMed ID: 12436661
    [No Abstract]   [Full Text] [Related]  

  • 20. Review of lipid-lowering clinical trials in relation to observational epidemiologic studies.
    Tyroler HA
    Circulation; 1987 Sep; 76(3):515-22. PubMed ID: 3304704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.